CPSA is a potent and competitive inhibitor against 20alpha-hydroxysteroid dehydrogenase (AKR1C1) with a Ki value of 0.86 nM. CPSA is promising for research of lung and endometrial cancers, premature birth and neuronal disorders[1].
Molecular Weight:
248.66
CAS Number:
[1038713-54-0]
Formula:
C13H9ClO3
Target:
Aldose Reductase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted